Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

IPO Education Foundation Names Medtronic's Dr. William J. Peine as 2026 Inventor of the Year

prnewswire.com
MDT BMY

Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson

globenewswire.com
ABBV AZN PFE NVS JNJ AMGN BMY GILD BIIB TXMD UTHR

Esophageal Cancer - 7MM Market Insights, Epidemiology, Competitive Landscape, and Forecast - 2036 | 6.0% CAGR Fueled by Immunotherapy and Precision Oncology

globenewswire.com
MRK BMY AZN ABBV AMGN JAZZ ZYME BIIB

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) - Market Insights, Epidemiology, and Forecast - 2036 | Radioligand Innovation Unlocks 7MM Growth Opportunities

globenewswire.com
EXEL BMY PFE REGN

Head and Neck Squamous Cell Carcinoma (HNSCC) - Market Insights, Epidemiology, and Market Forecast - 2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care

globenewswire.com
MRK BMY JNJ PDS BNTX INO IMPP CUE

CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J

globenewswire.com
BMY GILD JNJ

Synthetic Biology Market Size, Share, Growth, Trends, Applications, Competitive Landscape, and Forecast, 2026 to 2034 | 17.6% CAGR Fuels AI-Driven Biomanufacturing Opportunities

globenewswire.com
GNS TWST TMO BMY GEN CODX MRK

Small Molecule Drug Discovery - Global Strategic Business Report Forecasts Growth from $61.5B (2024) to $100B by 2030, Profiling AstraZeneca, Gilead Sciences, Merck & Pfizer

globenewswire.com
AZN GILD MRK PFE BMY JNJ TEVA

Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa

accessnewswire.com
BMY

Global Aptamer-Drug Conjugates Market Outlook, 2026-2032 - AI-Enabled Discovery and Precision Delivery Drive Growth Toward USD 2.14 Billion at a 15.79% CAGR

globenewswire.com
ABBV ADCT AZN BMY GSK MRK PFE ROG TAK ZYME